Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 133

1.
2.

Substituted 2-phenyl-benzimidazole derivatives: novel compounds that suppress key markers of allergy.

Richards ML, Lio SC, Sinha A, Banie H, Thomas RJ, Major M, Tanji M, Sircar JC.

Eur J Med Chem. 2006 Aug;41(8):950-69. Epub 2006 May 2.

PMID:
16647159
3.

Vaccines targeting IgE in the treatment of asthma and allergy.

Peng Z.

Hum Vaccin. 2009 May;5(5):302-9. Epub 2009 May 18. Review.

PMID:
19221515
4.

Immunoglobulin E: role in asthma and allergic disease: lessons from the clinic.

Owen CE.

Pharmacol Ther. 2007 Jan;113(1):121-33. Epub 2006 Sep 25. Review.

PMID:
17000005
5.

Novel selective orally active CRTH2 antagonists for allergic inflammation developed from in silico derived hits.

Ulven T, Receveur JM, Grimstrup M, Rist Ø, Frimurer TM, Gerlach LO, Mathiesen JM, Kostenis E, Uller L, Högberg T.

J Med Chem. 2006 Nov 16;49(23):6638-41.

PMID:
17154491
6.

Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.

Chang TW, Wu PC, Hsu CL, Hung AF.

Adv Immunol. 2007;93:63-119.

PMID:
17383539
7.
8.

Control of IgE and selective T(H)1 and T(H)2 cytokines by PG102 isolated from Actinidia arguta.

Park EJ, Kim B, Eo H, Park K, Kim Y, Lee HJ, Son M, Chang YS, Cho SH, Kim S, Jin M.

J Allergy Clin Immunol. 2005 Nov;116(5):1151-7.

PMID:
16275390
9.

Synthesis of benzimidazole derivatives as antiallergic agents with 5-lipoxygenase inhibiting action.

Nakano H, Inoue T, Kawasaki N, Miyataka H, Matsumoto H, Taguchi T, Inagaki N, Nagai H, Satoh T.

Chem Pharm Bull (Tokyo). 1999 Nov;47(11):1573-8.

PMID:
10605056
10.

New perspectives on mechanisms underlying chronic allergic inflammation and asthma in 2007.

Broide D.

J Allergy Clin Immunol. 2008 Sep;122(3):475-80. doi: 10.1016/j.jaci.2008.06.025. Epub 2008 Aug 9. Review.

PMID:
18694589
11.

The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation.

Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C.

J Allergy Clin Immunol. 2005 Mar;115(3):459-65. Review.

PMID:
15753888
12.

Anti-IgE therapy.

Jardieu P.

Curr Opin Immunol. 1995 Dec;7(6):779-82. Review.

PMID:
8679119
13.

Engineered recombinant ovomucoid third domain can modulate allergenic response in Balb/c mice model.

Rupa P, Mine Y.

Biochem Biophys Res Commun. 2006 Apr 14;342(3):710-7. Epub 2006 Feb 9.

PMID:
16494843
14.
16.

Anti-immunoglobulin E treatment with omalizumab in allergic diseases: an update on anti-inflammatory activity and clinical efficacy.

Holgate ST, Djukanović R, Casale T, Bousquet J.

Clin Exp Allergy. 2005 Apr;35(4):408-16. Review.

PMID:
15836747
17.

Therapeutic potential of anti-IgE antibodies.

Heusser C, Jardieu P.

Curr Opin Immunol. 1997 Dec;9(6):805-13. Review.

PMID:
9492982
18.

Intestinal helminths protect in a murine model of asthma.

Kitagaki K, Businga TR, Racila D, Elliott DE, Weinstock JV, Kline JN.

J Immunol. 2006 Aug 1;177(3):1628-35.

19.

Omalizumab : other indications and unanswered questions.

Mankad VS, Burks AW.

Clin Rev Allergy Immunol. 2005 Aug;29(1):17-30. Review.

PMID:
16222081
20.

Anti-IgE antibodies for the treatment of asthma.

Buhl R.

Curr Opin Pulm Med. 2005 Jan;11(1):27-34. Review.

PMID:
15591885

Supplemental Content

Support Center